210 related articles for article (PubMed ID: 16168280)
1. Aspirin resistance and atherothrombotic disease.
Mason PJ; Jacobs AK; Freedman JE
J Am Coll Cardiol; 2005 Sep; 46(6):986-93. PubMed ID: 16168280
[TBL] [Abstract][Full Text] [Related]
2. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
Chapman MJ
Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
[TBL] [Abstract][Full Text] [Related]
3. Aspirin resistance: current concepts.
Mason PJ; Freedman JE; Jacobs AK
Rev Cardiovasc Med; 2004; 5(3):156-63. PubMed ID: 15346099
[TBL] [Abstract][Full Text] [Related]
4. Current evidence and clinical implications of aspirin resistance.
Kasotakis G; Pipinos II; Lynch TG
J Vasc Surg; 2009 Dec; 50(6):1500-10. PubMed ID: 19679423
[TBL] [Abstract][Full Text] [Related]
5. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
Mohler ER
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
[TBL] [Abstract][Full Text] [Related]
6. Clinical implications of aspirin resistance.
Zimmermann N; Hohlfeld T
Thromb Haemost; 2008 Sep; 100(3):379-90. PubMed ID: 18766252
[TBL] [Abstract][Full Text] [Related]
7. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
Toth PP
Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
[TBL] [Abstract][Full Text] [Related]
8. Residual risk for secondary ischemic events in patients with atherothrombotic disease: opportunity for future improvements in patient care.
Pepine CJ
Ann Med; 2010; 42(1):19-35. PubMed ID: 20092398
[TBL] [Abstract][Full Text] [Related]
9. Aspirin resistance.
Ashwin KA; Bairy KL; Vidyasagar S; Verma M; Prashanth CK; Sachidananda A
Indian J Physiol Pharmacol; 2007; 51(2):109-17. PubMed ID: 18175654
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of aspirin resistance.
Patel D; Moonis M
Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):969-75. PubMed ID: 17867925
[TBL] [Abstract][Full Text] [Related]
11. Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.
Zimmermann N; Gams E; Hohlfeld T
Eur J Cardiothorac Surg; 2008 Jul; 34(1):93-108. PubMed ID: 18448350
[TBL] [Abstract][Full Text] [Related]
12. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
Maree AO; Fitzgerald DJ
Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
[No Abstract] [Full Text] [Related]
13. Aspirin resistance: biological and clinical implications.
Tseeng S; Arora R
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):5-12. PubMed ID: 18287586
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
Jennings LK
Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
[TBL] [Abstract][Full Text] [Related]
15. A critical appraisal of the phenomenon of aspirin resistance.
Svenstrup Poulsen T; Kristensen SR; Atar D; Mickley H
Cardiology; 2005; 104(2):83-91. PubMed ID: 16020925
[TBL] [Abstract][Full Text] [Related]
16. Aspirin resistance or variable response or both?
Cheng X; Chen WH; Simon DI
Am J Cardiol; 2006 Nov; 98(10A):11N-17N. PubMed ID: 17097412
[TBL] [Abstract][Full Text] [Related]
17. Facts and controversies of aspirin and clopidogrel therapy.
Faxon DP; Freedman JE
Am Heart J; 2009 Mar; 157(3):412-22. PubMed ID: 19249409
[TBL] [Abstract][Full Text] [Related]
18. The role of aspirin in cardiovascular prevention: implications of aspirin resistance.
Gasparyan AY; Watson T; Lip GY
J Am Coll Cardiol; 2008 May; 51(19):1829-43. PubMed ID: 18466797
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
[TBL] [Abstract][Full Text] [Related]
20. TP receptor antagonism: a new concept in atherothrombosis and stroke prevention.
Chamorro A
Cerebrovasc Dis; 2009; 27 Suppl 3():20-7. PubMed ID: 19439937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
